ATGC Co., Ltd. announced a private placement of 10,500 common shares at a price of KRW 200,000 for gross proceeds of KRW 2,100,000,000 on January 4, 2019. The transaction will include participation from new investor EuBiologics Co., Ltd. (KOSDAQ:A206650) for 10,500 shares for in the transaction. The shares will be issued through third part allotment method. The equity ratio of the investor will be 3.04% after the transaction. The transaction was approved by the board of directors of the company. The transaction is expected to close on January 10, 2019. The transaction is approved by the shareholders of the investor.